Aemetis (NASDAQ:AMTX) Shares Cross Below 200-Day Moving Average of $4.34

Aemetis, Inc. (NASDAQ:AMTX) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.34 and traded as low as $4.31. Aemetis shares last traded at $4.47, with a volume of 618,498 shares traded.

Analyst Ratings Changes

AMTX has been the topic of a number of recent analyst reports. Stifel Nicolaus dropped their price target on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Wednesday, February 21st. Truist Financial lowered their price objective on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating for the company in a research note on Tuesday, January 23rd.

Aemetis Stock Performance

The firm’s 50 day moving average price is $4.05 and its two-hundred day moving average price is $4.34. The company has a market cap of $190.46 million, a P/E ratio of -3.39 and a beta of 1.01.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. The business had revenue of $70.76 million for the quarter, compared to the consensus estimate of $80.08 million. During the same quarter last year, the firm posted ($0.63) EPS. As a group, analysts forecast that Aemetis, Inc. will post -1.44 EPS for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently bought and sold shares of AMTX. Point72 Asset Management L.P. bought a new stake in Aemetis during the 2nd quarter valued at $25,000. Barclays PLC increased its stake in Aemetis by 542.0% during the 4th quarter. Barclays PLC now owns 8,031 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 6,780 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in Aemetis by 173.7% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 3,545 shares during the last quarter. Deutsche Bank AG boosted its holdings in Aemetis by 66.9% during the 1st quarter. Deutsche Bank AG now owns 18,454 shares of the specialty chemicals company’s stock worth $43,000 after acquiring an additional 7,395 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its holdings in Aemetis by 105.6% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,517 shares of the specialty chemicals company’s stock worth $47,000 after acquiring an additional 4,887 shares during the last quarter. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.